CFSRE retweeted
💥 Q1 & Q2 2023 Drug Checking Quarterly Report #Philadelphia #PA
🆕 Format with more insights on purity/amount of #fentanyl, #xylazine, #cocaine, #meth, & more‼️
@CFSRE_ @PHLPublicHealth @Danny_Silva_md @alexkrotulski @Jenfir215 @barrylogantox
🔗: cfsre.org/nps-discovery/drug…
CFSRE retweeted
🎇🎆 Year in Review 2022 🎆🎇
@CFSRE_ and @NPSDiscovery are excited to release this new report of cumulative and updated statistics about the emergence and landscape of #NPS in the U.S. ⬇️⬇️⬇️
In 2022, our lab detected more than 75 individual NPS‼️
📄: cfsre.org/nps-discovery/tren…
CFSRE retweeted
These pictures bring back such GREAT memories! First two are from when I was 16 in my first summer as a HS @AmerChemSociety Project SEED research intern @CFSRE_ … Last one is me completing the very last extraction of samples for my Ph.D. research in 2019 in the very SAME lab!
CFSRE retweeted
Forensic science research and development has played a crucial role in the investigation and resolution of thousands of crimes since the late 1980s. In honor of #ForensicScienceWeek, learn about how NIJ-funded work is advancing the field of forensics: nij.ojp.gov/topics/forensics…
CFSRE retweeted
🎉🥳👏🏼
Congratulations to @CFSRE_ Fellow and @NPSDiscovery collaborator Donna Papsun @DMPtox for being awarded the inaugural Edward J Barbieri Award for Best Toxicology Paper during the annual @theNAME1966 meeting!!!
Your #NPS and #forensic contributions are unmatched ‼️‼️
CFSRE retweeted
**Just published!!** @NSCSafety Alcohol and Drugs Impairment Division toxicology testing guidelines for labs throughout the country to help combat drug impaired diving. bit.ly/3wNtDsr
CFSRE retweeted
#Protonitazene is the 7th benzimidazole (“nitazene”) opioid analogue identified in the #US in less than two years! Isotonitazene first emerged in mid/late 2019. Have the #nitazenes become the new #fentanyl #analogues ⁉️
CFSRE retweeted
AND ‼️ ... this marks @NPSDiscovery’s 100th new #NPS reported! It has been a rewarding three years serving #NPS impacted communities. 🙂
🎉🎉🎉
🚨 New Potent Opioid Alert 🚨
N-Pyrrolidino Etonitazene (Etonitazepyne) has been identified in the US. Emergence of this new #opioid could signify replacement of metonitazene. Check out our new monograph 👇 and keep an eye out for more information ‼️
📄: npsdiscovery.org/wp-content/…
CFSRE retweeted
Very pleased to have @BarryKLoganTox presenting @ #BLT Scientific Meeting & General Assembly.
👉 "Surveillance strategies for tracking emerging drug trends in the United States in the absence of a National Early Warning System",
👉 ~ to activities @ForSciResearch & @NPSDiscovery
CFSRE retweeted
.@NPSDiscovery is excited to announce the release of a new report!
The Drug Supply Assessment provides real-time and actionable data on specific drug market trends and comes as a collaborative effort between @ForSciResearch and @PHLPublicHealth
📄: npsdiscovery.org/wp-content/…
CFSRE retweeted
The Pre-Registration deadline for #AAFS2021 is finally upon us! Today is your last chance to save on costs and earn 500 leaderboard points. #OneAcademy
LEARN MORE: aafs2021.vfairs.com/
Don't forget to REGISTER for this year's 73rd AAFS Annual Scientific Meeting.
aafs.org/.../Meetings/2021-M…
Pre-register by January 18th and earn 500 points to our virtual platform leaderboard.
CFSRE retweeted
With the support of @ForSciResearch & @Kurabiotech, our 3-day inaugural #virtual meeting in #clinical & #forensic #toxicology made history with participants from 38 countries, 31 speakers, 19 hours of continuing #education #CE in 6 different languages. Join our digital movement
CFSRE retweeted
NMS Labs is pleased to sponsor "Cannabinoid Quantitation in Plants and Beyond: Liquid, Oils, Vape Cartridges, and Edibles" on 1.18.21. This will take place during the Online Forensic Symposium: Current Trends in Seized Drug Analysis. Register today: ow.ly/fZO350D0mzN
CFSRE retweeted
🔍@ForSciResearch : MeO-PCE is classified as a novel #hallucinogen. Novel #hallucinogens have been reported
to cause effects similar to #ketamine and PCP. Novel hallucinogens have caused adverse events, including deaths, as described in the literature.
▶️npsdiscovery.org/wp-content/…
A new drug monograph is now available for MeO-PCE, an #NPS hallucinogen identified in the US. While this isn’t a new drug to some, this is its first appearance at our lab, and no data is publicly available in regard to positivity and prevalence.
📄: npsdiscovery.org/wp-content/…
CFSRE retweeted
Attending Hot Topics in Neonatology? Dr. Kari Midthun will be available to answer questions regarding newborn toxicology testing and compare umbilical cord with meconium and urine. Arrange a time to meet today: ow.ly/IeYE50CtLu5
#neonatology #NICU #pediatrics #toxicology
Keynote @VIINPSConf NPS discovery: A programme for early detection of emerging trends in novel drugs in the United States — Barry Logan, @NMS_Labs , United States
Keynote @VIINPSConf ‘How to maintain activities during a crisis period’ – O. Rabin, World-Anti Doping Agency (WADA) @wada_ama
CFSRE retweeted
🚨📄 Excited to announce the availability of our newest publication describing the #NPS #opioid brorphine. This paper includes 20 #forensic cases from the U.S. implicating this new drug.
Visit @AAFSorg Journal of Forensic Sciences to access the paper: onlinelibrary.wiley.com/doi/…
CFSRE retweeted
AP-238 is available in the HighResNPS October 2020 library courtesy of data provided by @NPSDiscovery and @ForSciResearch.
If you have analytical data for this substance, please add it to HighResNPS or DM us!
🚨A new #NPS #opioid has been identified in the United States. Differing from fentanyl, AP-238 is a cinnamylpiperazine with close structural resemblance to other AP-### analogues. This new opioid was identified in a toxicology sample from the Midwest.
📄: npsdiscovery.org/wp-content/…
CFSRE retweeted
Brorphine remains a danger to those who use this new synthetic opioid unknowingly or unsuspectedly. News reports continue to emerge as brorphine-involved deaths increase.
Our research team is working quickly to publish our results and case series!
centralillinoisproud.com/new…
































